BioCatalystWatch
ATNMWorkspace / ATNM / OverviewCompany library
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc. (ATNM)

Website

Price
Market cap
Next catalystDec 9, 2026ATNM-400 — breast cancer preclinical models · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ATNM-400

HER3

Upcoming / outlook

ATNM-400

HER3

Upcoming / outlook

  • Timing and evidence

Iomab-ACT

CD45

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Iomab-ACT

CD45

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Iomab-ACT

CD45

PreINDP1P2P3FilingApproved
Actimab-A

CD33

PreINDP2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Iomab-ACT

CD45

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

ATNM-400

HER3

Upcoming / outlook

ATNM-400

HER3

Upcoming / outlook

  • Timing and evidence

Iomab-ACT

CD45

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Actimab-A

CD33

PreINDP2P3FilingApproved
Upcoming / outlook

Iomab-ACT

CD45

PreINDP1P2P3FilingApproved

Other pipelines

ATNM-400

HER3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Iomab-ACT

CD45

PreINDP1P2P3FilingApproved
Actimab-A

CD33

PreINDP2P3FilingApproved
Actimab-A

CD33

PreINDP1P2P3FilingApproved
Actimab-A

CD33

PreINDP1P2P3FilingApproved
Ac-225-HER3-ARC

HER3 (ErbB3)

PreINDP1P2P3FilingApproved

History / paused

Actimab-A

CD33

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ATNM PR & News

PR & News

ATNM SEC archive